Northern Trust
MGRX icon

Northern Trust’s Mangoceuticals MGRX Stock Holding History

Northern Trust’s Portfolio MGRX Stock Details MGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.3K Hold
37,579
– – ﹤0.01% 4395
2026
Q1 		$13.5K Hold
37,579
– – ﹤0.01% 4362
2025
Q4 		$27.8K Buy
37,579
+18,622
+98% +$30.2K ﹤0.01% 4359
2025
Q3 		$41.5K Buy
+18,957
New +$35.3K ﹤0.01% 4306

Other funds holding MGRX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
ACA
Ackerman Capital Advisors Dallas, Texas $497M AUM 16.31% 1-Year Est. Return
AA
ACT Advisors Asheville, North Carolina $301M AUM 23.36% 1-Year Est. Return
CAG
Csenge Advisory Group Clearwater, Florida $2.47B AUM 24.93% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $80B AUM 26.12% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Northern Trust's MGRX Position: Q2 2026 in Review

Northern Trust held its Mangoceuticals (MGRX) position steady in Q2 2026 at 37,579 shares worth $14.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4395.

Northern Trust first reported a position in MGRX in Q3 2025 and has held it in 4 quarters since. The position peaked at $41.5K in Q3 2025. 11 funds tracked by Wall St. Rank hold MGRX as of Q2 2026.

  • Northern Trust held 37,579 shares of Mangoceuticals worth $14.3K as of Q2 2026.
  • Northern Trust left its Mangoceuticals share count unchanged in Q2 2026.
  • Mangoceuticals made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4395 holding.
  • Northern Trust first reported a position in Mangoceuticals in Q3 2025 and has held it in 4 quarters since.
  • Northern Trust's Mangoceuticals position peaked at $41.5K in Q3 2025.
  • 11 funds tracked by Wall St. Rank held Mangoceuticals as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.